Many algorithms have been developed to retrieve phase from a group of phase-shifted interferograms.
The results for each group of phase-to-ground, phase-to-phase-to-ground, and phase-to-phase faults are similar.
We analyzed outcomes in a group of phase 2 study patients treated with dose-escalated proton therapy with concurrent chemotherapy for stage 3 non-small cell lung cancer (NSCLC).
In effort to solve these problems, we designed a group of signals based on orthogonal waveforms, then used a genetic algorithm to design a group of phase-coding signals, and finally analyzed the system as established in terms of time measurement precision, performance in the multipath environment, and the aliasing effects of multi-target signals.
Inclusion criteria for FMS + M1 with prophylaxis were the same as for the FMS + M1 group of phase 1, plus: habitual acute medication for fibromyalgia flares represented by paracetamol 1 g; willingness to undergo migraine prophylaxis with calcium-channel blockers; no contraindications to treatment with this drug class [33, 34].
The second group of phase II mice received vibrations only during RA, but not during HU (VIB-RA, n = 6).
Because of the nature of the permutation test, which included a large group of phase locking values, a few subjects with very large differences could dominate the overall average difference.
In the first group of phase II mice, 15 min of the daily vibratory stimulus described above was applied only during HU but not during RA (VIB-HU, n = 6).
The cytochrome P450 family (CYP450) is the main group of Phase I enzymes, contributing to the metabolism of various endogenous and xenobiotic compounds [ 1].
Therefore, in a typical group of phase I patients with a variety of tumour sites (e.g., cutaneous/subcutaneous disease, lung, bone or nodal metastases), it will not be possible to ensure that all normal organ systems are assessed in all, or any, of the three patients in each dose level.
